Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Am J Obstet Gynecol ; 226(3): 379-383, 2022 03.
Artigo em Inglês | MEDLINE | ID: mdl-34111406

RESUMO

In the past, the reproductive freedom of African American women was hindered by forced reproduction and sterilization campaigns. Unfortunately, these involuntary practices have now mostly been replaced by inequality because of disproportionate tubal factor infertility rates within African American communities. Our work aimed to describe the inequities in increased rates of pelvic inflammatory disease and tubal factor infertility as it relates to African American women. In addition, we highlighted the need for improved access to screening and treatment of sexually transmitted infections, access to barrier contraception, and health literacy related to the understanding and prevention of tubal factor infertility in African American women.


Assuntos
Infertilidade Feminina , Infertilidade , Doença Inflamatória Pélvica , Negro ou Afro-Americano , Feminino , Liberdade , Humanos , Infertilidade/complicações , Infertilidade Feminina/etiologia , Doença Inflamatória Pélvica/diagnóstico , Reprodução
2.
Clin Perinatol ; 46(2): 187-201, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-31010555

RESUMO

Cerebral palsy occurs more often in preterm than in term deliveries and is one of the major neurologic injuries seen in preterm infants. Magnesium sulfate has been found to reduce the risk of cerebral palsy in patients at risk of delivery before 32 weeks' gestational age. Multiple large clinical trials have shown this effect. The authors recommend magnesium sulfate bolus followed by continuous dosing of magnesium sulfate in those at risk of delivery before 32 weeks' gestation until delivery occurs or is no longer imminent. This article also discusses novel and emerging therapies for the prevention of cerebral palsy.


Assuntos
Paralisia Cerebral/prevenção & controle , Sulfato de Magnésio/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Trabalho de Parto Prematuro , Nascimento Prematuro , Darbepoetina alfa/uso terapêutico , Eritropoetina/uso terapêutico , Feminino , Hematínicos/uso terapêutico , Humanos , Hipotermia Induzida , Recém-Nascido , Recém-Nascido Prematuro , Precondicionamento Isquêmico , Troca Materno-Fetal , Transplante de Células-Tronco Mesenquimais , Neuroproteção , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA